ABUS vs PG
Arbutus Biopharma Corp (ABUS) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ABUS and PG stock pages for the full models.
Not investment advice.